What Influences Patient Outcome in Obstructive Airway Disease?

This study has been completed.
Sponsor:
Information provided by:
University of Dundee
ClinicalTrials.gov Identifier:
NCT01221480
First received: October 14, 2010
Last updated: October 19, 2010
Last verified: October 2010

October 14, 2010
October 19, 2010
August 2010
Not Provided
All-cause Mortality
Same as current
Complete list of historical versions of study NCT01221480 on ClinicalTrials.gov Archive Site
  • Hospital Admissions
  • COPD exacerbations
Same as current
Not Provided
Not Provided
 
What Influences Patient Outcome in Obstructive Airway Disease?
Beta-Blockers Reduce Mortality and Exacerbations When Added to Stepwise Inhaled Therapy for COPD Without Adverse Effects on Lung Function.

The aim of this observational study is to utilise the established record linkage data available in Tayside to investigate hospital admissions, exacerbations and mortality in COPD.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Retrospective
Not Provided
Not Provided
Probability Sample

COPD patients within NHS Tayside, UK

COPD
Not Provided
  • Beta Blocker Use
  • No beta blocker use
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
5977
October 2010
Not Provided

Inclusion Criteria:

  • Data collected through TARDIS database

Exclusion Criteria:

  • History of asthma or malignancy. Less than 50 years of age
Both
50 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT01221480
SHO002
No
Dr Philip M Short, University of Dundee
University of Dundee
Not Provided
Not Provided
University of Dundee
October 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP